News

Citi Upgrades Polycab Target: Strong Growth Forecast Ahead

Citi Upgrades Polycab Target: Strong Growth Forecast Ahead

Citi Boosts Polycab Price Target Amid Growth Projections

In a recent update, Polycab India Limited (POLYCAB:IN) has garnered the attention of Citi, which has raised its price target from INR 8,400 to INR 8,600. This adjustment comes alongside a retained Buy rating for the stock, reinforcing the company's strong market presence.

Insights from Citi's Analysis

Citi's analysis delves into the key drivers behind Polycab's expected success. The firm's review emphasizes the management's perspective regarding the competitive landscape of the Wires & Cables segment, particularly its impact on profit margins. There's a clear expectation for an uptick in demand as we move into the latter half of the year.

Projected Demand Growth

The management team at Polycab is optimistic about demand growth during this upcoming period. They forecast that margins during the second half of the year typically outperform those in the first half, a trend they expect to persist moving forward.

Robust Order Book and Strategic Investments

Furthermore, Polycab's Others/EPC division is anticipated to maintain a steady quarterly run rate over the next couple of years, thanks to a solid RDSS order book showcasing a backlog of approximately INR 48 billion. In addition, Polycab has plans to allocate INR 10-12 billion in capital expenditures annually over the next two to three years, underlining their commitment to growth and expansion.

Revenue and EPS Adjustments

While the EPC segment is poised to maintain a significant contribution to overall revenue, Citi also notes that a revival in export activities could enhance margin recovery. As such, the firm has revised its revenue forecasts for Polycab for FY25-27E upwards by 4-5%, indicating stronger growth than previously anticipated. Conversely, EPS estimates have been slightly trimmed by 1-5% due to the anticipated decrease in margins.

Polycab's Market Position

The modifications in price targets and earnings forecasts reflect Citi's adjusted perspective on Polycab's target price, which now integrates a target P/E multiple of 52x projected for September 2026. With these developments, Polycab reaffirms its status as a top pick within the Consumer Durable/Electrical sector, as per Citi's recommendations, signaling an optimistic view on the company's performance and maintaining a solid market position.

Frequently Asked Questions

What is the new price target for Polycab as per Citi?

Citi has raised the price target for Polycab from INR 8,400 to INR 8,600.

What factors are contributing to Polycab's growth?

Key factors include expected demand growth, management insights, and a robust order backlog.

How has Citi adjusted its revenue estimates for Polycab?

Citi has increased its revenue estimates for FY25-27E by 4-5%, reflecting positive growth.

What future investments are planned by Polycab?

Polycab plans to invest INR 10-12 billion annually in capital expenditures over the next two to three years.

Why does Citi maintain a Buy rating on Polycab?

Citi's Buy rating is based on Polycab's strong growth prospects and favorable market conditions within the sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Operational Investments That Pay Off: From Equipment to Efficiency

Updated Category Investing Views 913

Profit margins don’t grow on paper. They’re built in fields, on job sites, and across every mile a work truck covers. While most investors fixate on markets and financial instruments, the decisions that shape long-term returns often come down to how a business invests in its day-to-day operations. From machinery to mobility, the assets that power a company’s core...

Continue Reading
Capricor Therapeutics Boosts Market Confidence with New Deals

Updated Category News Views 82

Capricor Therapeutics Jump as Oppenheimer Updates Price Target Oppenheimer has recently adjusted its forecast for Capricor Therapeutics (NASDAQ: CAPR), increasing the price target from $14.00 to $15.00, while maintaining an Outperform rating for the stock. This revision follows Capricor's announcement that they have established binding terms for the European...

Continue Reading
Twelve Labs Partners with AWS to Revolutionize Video Search

Updated Category News Views 186

Transforming Video Content into Searchable Data In a significant move for the field of artificial intelligence, Twelve Labs is collaborating with Amazon Web Services (AWS) to enhance the way videos are analyzed and interacted with. This partnership strives to make video content as searchable and accessible as text, an advancement that many experts believe is crucial in...

Continue Reading
Mustang Energy Commences Uranium Exploration at New Project

Updated Category News Views 211

Mustang Energy Begins Exploration at Cluff Lake North Project Mustang Energy Corp. (CNSX: MEC.CN, Other OTC: MECPF, Frankfurt: 92T) has officially started its exploration activities at the Cluff Lake North Project. This project is situated in the renowned Athabasca Basin, a region celebrated for its rich mineral potential. The company has recently secured an option...

Continue Reading
Explore Romantic Getaways: Top Valentine's Day Travel Picks

Updated Category News Views 254

Embrace the Spirit of Romance This Valentine's Day As Valentine's Day approaches, many couples are beginning their journey toward unforgettable experiences rather than just exchanging gifts. This day symbolizes love and connection, inviting everyone to explore the world with their partner. Travel has become the new trend for celebrating this special occasion, with couples...

Continue Reading